Stryker To Pay $1.4M Over Bone Protein Marketing

Law360, New York (August 26, 2010, 12:27 PM EDT) -- Stryker Biotech LLC has agreed to pay $1.35 million to Massachusetts to settle claims that the company marketed its OP-1 bone protein for uses not approved by the U.S. Food and Drug Administration.

In a consent judgment lodged Wednesday in the Suffolk County Superior Court in Massachusetts, Stryker Biotech agreed to pay $875,000 to fund efforts to combat unlawful marketing in the health care industry, Massachusetts Attorney General Martha Coakley said in a statement Thursday.

The company, a subsidiary of Michigan-based medical technology giant Stryker Corp.,...
To view the full article, register now.